Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

R1 RCM

Health Tech & Medtech · Murray, United States · Founded 2003 · IPO 2010 Unicorn

Serves as the one revenue cycle management partner for select hospitals and healthcare systems regardless of their payment models

Valuation
$5–10B
Latest valuation · 2026
Unlock exact value
Revenue
$1–5B
Latest reported FY
Unlock exact value
Headcount
10–25k
Current team size
Unlock exact value

Investors

2 investors on R1 RCM's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage
Intermountain Healthcare
Khosla Ventures

Global footprint

Where R1 RCM has talent and traffic

AI talent share
0.2% of workforce is AI talent
(49 of 22,338 staff)
Core AI20.01%
Other AI470.21%
Non-AI workforce22,28999.78%
Workforce by country
20 countries with
team presence
🇮🇳 India61.5%
🇺🇸 United States33.6%
🇵🇭 Philippines4.2%
🇦🇪 United Arab Emirates0.1%
🇬🇧 United Kingdom0.1%
Top 5 of 20 shown
Web traffic by country
410K monthly visits
across markets
🇺🇸 United States92.5%
🇮🇳 India4.1%
🇨🇦 Canada0.7%
🇵🇭 Philippines0.7%
🇬🇧 United Kingdom0.4%
Top 5 markets shown

Patent intelligence

$503k patent portfolio · 8 active families

Estimated portfolio value
$503k
<0.01% of valuation · 4.7× smaller than top peer ZocDoc ($2M)
8 active patent families
Where R1 RCM innovates Medical careClient-sideSystems engineeringAutomated dataThird party

Where R1 RCM concentrates vs peers

Each axis is a top-10 topic across R1 RCM and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

R1 RCM's 5 investments and acquisitions.

Every disclosed deal where R1 RCM appeared as a backer or acquirer, 2018–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across R1 RCM's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        R1 RCM's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        What the market is saying about R1 RCM

        An AI-synthesized read of the highest-engagement posts about R1 RCM on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See R1 RCM on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.